Efficacy of Combined Immunotherapy and Targeted Therapy in Advanced Non-Small Cell Lung Cancer: A Randomized Controlled Trial

Maria G. Rodriguez, MD, PhD; David K. Park, MD; Emily J. Thompson, MD, MPH; Andrew C. Foster, MD, PhD

Background: The combination of immunotherapy with targeted therapy for advanced non-small cell lung cancer (NSCLC) remains an active area of investigation. This randomized controlled trial evaluates the efficacy and safety of pembrolizumab combined w...